Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity
Gtj. Huang et al., Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity, INT J ONCOL, 17(3), 2000, pp. 479-486
The intercellular adhesion molecule-1 (ICAM-1, CD54) serves as a counter-re
ceptor for the beta 2-integrins, LFA-1 and Mac-1, which are expressed on le
ukocytes. Although expression of ICAM-1 on tumor cells has a role in tumor
progression and development, information on ICAM-1 expression and its role
in oral cancer has not been established. Normal human oral keratinocytes (N
HOK), human papilloma virus (HPV)-immortalized human oral keratinocyte line
s (HOK-16B, HOK-18A, and HOK-18C), and six human oral neoplastic cell lines
(HOK-16B-BaP-T1, SCC-4, SCC-9, HEp-2, Tu-177 and 1483) were used to study
ICAM-1 expression and its functional role in vitro. Our results demonstrate
d that NHOK express negligible levels of ICAM-1, whereas immortalized human
oral keratinocytes and cancer cells express significantly higher levels of
ICAM-1, except for HOK-16B-BaP-T1 and HEp-2. Altered mRNA half-lives did n
ot fully account for the increased accumulation of ICAM-1 mRNA. Adhesion of
peripheral blood mononuclear cells (PBMC) to epithelial cells correlated w
ith cell surface ICAM-1 expression levels. This adhesion was inhibited by a
ntibodies specific for either ICAM-1 or LFA-1/Mac-1, suggesting a role for
these molecules in adhesion. In contrast, lymphokine-activated-killer (LAK)
cell cytotoxic killing of epithelial cells did not correlate with ICAM-1 l
evels or with adhesion. Nonetheless, within each cell line, blocking of ICA
M-1 or LFA-1/Mac-1 reduced LAK cell killing, suggesting that ICAM-1 is invo
lved in mediating this killing.